Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets
J Invest Dermatol
.
2016 Jul;136(7):1517-1520.
doi: 10.1016/j.jid.2016.03.001.
Epub 2016 Mar 11.
Authors
Hyunje Grace Cho
1
,
David Fiorentino
2
,
Matthew Lewis
2
,
Marina Sirota
3
,
Kavita Y Sarin
4
Affiliations
1
School of Medicine, Stanford University, Stanford, California, USA.
2
Department of Dermatology, Stanford University Medical Center, Stanford, California, USA.
3
Institute for Computational Health Sciences, University of California San Francisco, San Francisco, California, USA.
4
Department of Dermatology, Stanford University Medical Center, Stanford, California, USA. Electronic address: ksarin@stanford.edu.
PMID:
26975725
PMCID:
PMC5399882
DOI:
10.1016/j.jid.2016.03.001
No abstract available
Publication types
Letter
MeSH terms
Adrenergic alpha-Agonists / therapeutic use*
Datasets as Topic
Dermatomyositis / drug therapy*
Drug Repositioning*
Humans
Oxymetazoline / therapeutic use
Substances
Adrenergic alpha-Agonists
Oxymetazoline
Grant support
T32 AR050942/AR/NIAMS NIH HHS/United States